Xarelto Lawsuit Challenges Xarelto Daily Dosage Effectiveness

By | December 22, 2015

A newly filed Xarelto lawsuit challenged the 24-hours efficacy of the dreaded blood thinner medication. One of the main selling points of the overhyped blood thinner Xarelto was its “one size fits all” dosage. Xarelto did not require dose adjustment or constant blood monitoring, as a single pill every day was deemed sufficient to prevent the risk of developing dangerous blood clots in all types of patients. It didn’t matter if that patient weight was 200 lbs or just 120 lbs if he or she was 25 years old or 75 years old: Xarelto dosage was just one pill every 24 hours, and that’s it.

However on October 8, 2015, a new Xarelto lawsuit filed against Janssen Pharmaceuticals and Bayer AG explicitly accuses the pharmaceutical companies of marketing a medication that is not effective as it is promoted. The plaintiff in the lawsuit was a patient suffering from atrial fibrillation (Afib) who took Xarelto to reduce his risk of stroke, but he alleges that the blood thinner drug was ineffective. Many researchers and doctors already theorized that Xarelto once-daily dosage could not be enough to be effective in different patients, but this new lawsuit allegedly provide supporting evidence of this accusation. The plaintiff, in fact, suffered a stroke a couple of days after he started his Xarelto treatment: four to be exact.

On the other hand, the plaintiff alleges that Xarelto could be the cause of the stroke itself. Previous studies already highlighter a potential danger of brain strokes in patients who took Xarelto, but a final scientific consensus about Xarelto dangers has never been reached. The United States Food and Drug Administration (FDA) and the European Medicine Agency (EMA) recently decided to review the ROCKET-AF trial, the largest study that demonstrated Xarelto purported safety and effectiveness. Or, should we say Xarelto lack of safety and effectiveness?

Many other lawsuits already accused Xarelto of being a dangerous medication, mostly because it was released to market without an efficient method to reverse its action. The lack of a Xarelto antidote already caused dozens of deaths and thousands of severe injuries because of its life-threatening uncontrolled bleeding events. Doctors aren’t often able to save a patient’s life whenever one of these dreaded Xarelto side effects manifest, as blood transfusions or surgical interventions are seldom useful when there’s no way to stop the bleeding.

Due to the high number of Xarelto uncontrolled bleeding lawsuits, over 2,200 of them have been consolidated in the Multidistrict litigation (MDL) number 2592, overseen by the U.S. District Judge Eldon E. Fallon.